Clinical trial
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With…
NCT01281306 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT01281306 |
|---|---|
| Title | An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension |
| Official title | A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systolic Hypertension |
| Intervention type | Drug |
| Interventions | LCZ696, Valsartan, AHU377, Placebo |
| Enrollment | 910 |
| Start date | Jan 1, 2011 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jan 21, 2011 |
| Last update posted | Jan 29, 2016 |
| Countries | Argentina, Canada, Hungary, India, Romania, Slovakia, South Korea, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: